Track topics on Twitter Track topics that are important to you
Digital pathology software and hardware combine to manage the process from high-throughput scanning all the way to image analysis
Baltimore, Maryland (PRWEB) March 02, 2017
Proscia Inc, a data solutions provider for digital pathology, and Huron Digital Pathology, a provider of whole slide imaging solutions, today announced the two companies now provide seamless integration between Huron scanners and the Proscia digital pathology platform. Through this integration, pathologists will be able to quickly and easily scan slides and have them automatically uploaded to the Proscia cloud-based platform for storage, collaboration and image analysis.
Proscia and Huron will together demonstrate a high speed, integrated scanning and software environment at the upcoming USCAP conference, held at the Henry B. Gonzalez Convention Center in San Antonio, Texas, between March 6 and 8, 2017.
“As a scanner-agnostic solution, our open SaaS-based digital pathology platform is able to handle any image format,” said David West, Jr., Chief Executive Officer of Proscia. “At the same time, customers want tightly integrated solutions and often look for interoperability for their digital pathology needs. The speed and openness of Huron’s new TissueScope™ LE scanner platform made it the perfect complement to our software in creating an integrated platform for high-speed scanning and uploading.”
“We saw an opportunity for Huron to partner with Proscia to provide best-in-class scanner and software solutions that are well integrated and move the digital pathology industry forward in speed, power and ease of use,” said Patrick Myles, Chief Executive Officer of Huron. “Proscia’s Pathology Cloud platform provides instantaneous access to scanned slides, allowing them to be sent or retrieved from anywhere in the world, and its built-in image analysis tools enable pathologists to easily extract meaningful information from the images.”
By uploading scanned slides directly from Huron’s scanners into Proscia’s platform, pathologists have instant access to thousands of images and get immediate feedback from Proscia’s digital image analysis, including new learnings and information that cannot be detected or measured by the naked eye. Patterns emerge, helping pathologists make faster, more informed and accurate diagnoses and treatments.
Proscia will also be showing new case management features at USCAP that will tie closely to the workflow of pathology departments. Pathologists will now be able to organize and work through a case rather than image paradigm, grouping relevant images and data under one case for a single patient. For example, if one patient has had multiple scans, Proscia software will make it easy for pathologists to compare progress and changes between one sample and another.
At USCAP, visit Proscia at booth 539 and Huron Digital Pathology at booth 610 to see a demonstration of the integrated scanner-software solution.
Proscia, a Baltimore, MD company, was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed and quality of pathology diagnostics and research. To learn more, please visit https://www.proscia.com.
About Huron Digital Pathology
Based in Waterloo, Ontario, Canada, Huron Digital Pathology has a 20 year history designing sophisticated imaging instrumentation. Our end-to-end digital whole slide scanning solutions for digital pathology incorporate our award-winning TissueScope™ digital slide scanners and TissueSnap™ preview scanning station. Visit us at http://www.hurondigitalpathology.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/Proscia/Huron/prweb14103753.htmNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...